Compare INDI & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INDI | INMD |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 750.1M | 842.0M |
| IPO Year | 2021 | 2018 |
| Metric | INDI | INMD |
|---|---|---|
| Price | $4.20 | $14.81 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | $6.25 | ★ $17.33 |
| AVG Volume (30 Days) | ★ 6.0M | 741.8K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.95 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $217,394,000.00 | N/A |
| Revenue This Year | $25.54 | $1.74 |
| Revenue Next Year | $38.45 | $3.26 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | ★ 0.33 | N/A |
| 52 Week Low | $2.32 | $12.72 |
| 52 Week High | $6.05 | $16.74 |
| Indicator | INDI | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.25 | 67.22 |
| Support Level | $4.03 | $14.58 |
| Resistance Level | $4.77 | $15.23 |
| Average True Range (ATR) | 0.36 | 0.27 |
| MACD | 0.04 | 0.14 |
| Stochastic Oscillator | 58.51 | 81.82 |
Indie Semiconductor Inc caters to the autotech industry with semiconductors, photonics, and software platforms. The company's products include devices for a multitude of automotive applications spanning vision and radar processors, in-cabin wireless charging and USB power delivery, device interfacing through Apple CarPlay and Android Auto, and high-speed video and data connectivity. New products under evaluation or development include LiDAR, cybersecurity-enabled microcontrollers, and sensor-fusion processors. Its Photonics division mainly offers low-noise lasers, standard, and custom light sources. Geographically, the company generates the majority of its revenue from Greater China and the rest from the United States, Europe, South Korea, and other regions.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.